NEXTO NEXTO
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • ECOSYSTEM
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Mahesh Chavan a adăugat un sunet Alte
    2025-11-27 11:54:11 -
    Global Scleroderma Therapeutics Market to Reach $3.83 Billion by 2033, Growing at 4.03% CAGR
    Market Overview The global scleroderma therapeutics market size was valued at USD 2.66 billion in 2024 and is projected to grow from USD 2.79 billion in 2025 to reach USD 3.83 billion by 2033, exhibiting a CAGR of 4.03% during the forecast period (2025-2033). The global Scleroderma Therapeutics market is witnessing swift transformation driven by new consumer...
    0 Commentarii 0 Distribuiri 245 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Shreya Patil a adăugat un sunet Alte
    2026-01-20 06:01:30 -
    Scleroderma Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
    Scleroderma Therapeutics Market Segmentation, By Indication (Localized Scleroderma and Systemic Scleroderma), Treatment Type (Drug Treatment, Surgical Treatment, and Therapy), Drug Class (Immunosuppresses, ERA, CCBs, and PA), End User (Hospital, Specialty Clinics, Homecare Settings, and Others) – Industry Trends and Forecast to 2032 The global scleroderma therapeutics market size was...
    0 Commentarii 0 Distribuiri 9 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Shreya Patil a adăugat un sunet Alte
    2025-10-03 05:31:10 -
    Scleroderma Therapeutics Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
    Scleroderma Therapeutics Market Segmentation, By Indication (Localized Scleroderma and Systemic Scleroderma), Treatment Type (Drug Treatment, Surgical Treatment, and Therapy), Drug Class (Immunosuppresses, ERA, CCBs, and PA), End User (Hospital, Specialty Clinics, Homecare Settings, and Others) – Industry Trends and Forecast to 2032 The global scleroderma therapeutics market size was...
    0 Commentarii 0 Distribuiri 391 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 NEXTO Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Community Guidelines Tokenomics Roadmap & Updates Security & Safety Tips FAQ Cookie Policy Contacteaza-ne Director